Literature DB >> 18162546

Replication stress induces tumor-like microdeletions in FHIT/FRA3B.

Sandra G Durkin1, Ryan L Ragland, Martin F Arlt, Jennifer G Mulle, Stephen T Warren, Thomas W Glover.   

Abstract

Common fragile sites (CFSs) are loci that preferentially exhibit metaphase chromosome gaps and breaks after partial inhibition of DNA synthesis. The fragile site FRA3B, which lies within the FHIT tumor-suppressor gene, is a site of frequent heterozygous and homozygous deletions in many cancer cells and precancerous lesions. The great majority of FHIT and other CFS-associated gene rearrangements in tumors are submicroscopic, intralocus deletions of hundreds of kilobases that often result in inactivation of associated genes. Although CFS instability leads to chromosome gaps and breaks and translocations, there has been no direct evidence showing that CFS instability or replication stress can generate large submicroscopic deletions of the type seen in cancer cells. Here, we have produced FHIT/FRA3B deletions closely resembling those in tumors by exposing human-mouse chromosome 3 somatic hybrid cells to aphidicolin-mediated replication stress. Clonal cell populations were analyzed for deletions by using PCR, array comparative genomic hybridization (aCGH), and FISH. Thirteen percent to 23% of clones exhibited submicroscopic FHIT deletions spanning approximately 200-600 kb within FRA3B. Chromosomes with FRA3B deletions exhibited significantly decreased fragility of this locus, with a 2- to 12-fold reduction in metaphase gaps and breaks compared with controls. Sequence analysis showed no regions of homology at breakpoints and suggests involvement of NHEJ in generating the deletions. Our results demonstrate that replication stress induces a remarkably high frequency of tumor-like microdeletions that reduce fragility at a CFS in cultured cells and suggests that similar conditions during tumor formation lead to intralocus deletion and inactivation of genes at CFSs and perhaps elsewhere in the genome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18162546      PMCID: PMC2224195          DOI: 10.1073/pnas.0708097105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  Molecular basis for expression of common and rare fragile sites.

Authors:  Eitan Zlotorynski; Ayelet Rahat; Jennifer Skaug; Neta Ben-Porat; Efrat Ozeri; Ruth Hershberg; Ayala Levi; Stephen W Scherer; Hanah Margalit; Batsheva Kerem
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

2.  ATR regulates fragile site stability.

Authors:  Anne M Casper; Paul Nghiem; Martin F Arlt; Thomas W Glover
Journal:  Cell       Date:  2002-12-13       Impact factor: 41.582

3.  Preferential integration of marker DNA into the chromosomal fragile site at 3p14: an approach to cloning fragile sites.

Authors:  F V Rassool; T W McKeithan; M E Neilly; E van Melle; R Espinosa; M M Le Beau
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

4.  Molecular characterization of a common fragile site (FRA7H) on human chromosome 7 by the cloning of a simian virus 40 integration site.

Authors:  D Mishmar; A Rahat; S W Scherer; G Nyakatura; B Hinzmann; Y Kohwi; Y Mandel-Gutfroind; J R Lee; B Drescher; D E Sas; H Margalit; M Platzer; A Weiss; L C Tsui; A Rosenthal; B Kerem
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

5.  High frequency of LOH, MSI and abnormal expression of FHIT in gastric cancer.

Authors:  C Huiping; S Kristjansdottir; J T Bergthorsson; J G Jonasson; J Magnusson; V Egilsson; S Ingvarsson
Journal:  Eur J Cancer       Date:  2002-03       Impact factor: 9.162

6.  WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer.

Authors:  A K Bednarek; K J Laflin; R L Daniel; Q Liao; K A Hawkins; C M Aldaz
Journal:  Cancer Res       Date:  2000-04-15       Impact factor: 12.701

7.  Cloning and characterization of the common fragile site FRA6F harboring a replicative senescence gene and frequently deleted in human tumors.

Authors:  Cristina Morelli; Efthimia Karayianni; Chiara Magnanini; Andrew J Mungall; Erik Thorland; Massimo Negrini; David I Smith; Giuseppe Barbanti-Brodano
Journal:  Oncogene       Date:  2002-10-17       Impact factor: 9.867

8.  Human papillomavirus type 16 integrations in cervical tumors frequently occur in common fragile sites.

Authors:  E C Thorland; S L Myers; D H Persing; G Sarkar; R M McGovern; B S Gostout; D I Smith
Journal:  Cancer Res       Date:  2000-11-01       Impact factor: 12.701

9.  BRCA1 is required for common-fragile-site stability via its G2/M checkpoint function.

Authors:  Martin F Arlt; Bo Xu; Sandra G Durkin; Anne M Casper; Michael B Kastan; Thomas W Glover
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

10.  Identification of unstable sequences within the common fragile site at 3p14.2: implications for the mechanism of deletions within fragile histidine triad gene/common fragile site at 3p14.2 in tumors.

Authors:  Shantel Corbin; Mary E Neilly; Rafael Espinosa; Elizabeth M Davis; Timothy W McKeithan; Michelle M Le Beau
Journal:  Cancer Res       Date:  2002-06-15       Impact factor: 12.701

View more
  69 in total

1.  Genomic rearrangements at the FRA2H common fragile site frequently involve non-homologous recombination events across LTR and L1(LINE) repeats.

Authors:  Lena M Brueckner; Evgeny Sagulenko; Elisa M Hess; Diana Zheglo; Anne Blumrich; Manfred Schwab; Larissa Savelyeva
Journal:  Hum Genet       Date:  2012-04-05       Impact factor: 4.132

2.  Deletion at fragile sites is a common and early event in Barrett's esophagus.

Authors:  Lisa A Lai; Rumen Kostadinov; Michael T Barrett; Daniel A Peiffer; Dimitry Pokholok; Robert Odze; Carissa A Sanchez; Carlo C Maley; Brian J Reid; Kevin L Gunderson; Peter S Rabinovitch
Journal:  Mol Cancer Res       Date:  2010-07-20       Impact factor: 5.852

Review 3.  Hits, Fhits and Nits: beyond enzymatic function.

Authors:  Kay Huebner; Joshua C Saldivar; Jin Sun; Hidetaka Shibata; Teresa Druck
Journal:  Adv Enzyme Regul       Date:  2010-10-28

Review 4.  Comparative genomics and molecular dynamics of DNA repeats in eukaryotes.

Authors:  Guy-Franck Richard; Alix Kerrest; Bernard Dujon
Journal:  Microbiol Mol Biol Rev       Date:  2008-12       Impact factor: 11.056

Review 5.  Break-induced DNA replication.

Authors:  Ranjith P Anand; Susan T Lovett; James E Haber
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-12-01       Impact factor: 10.005

Review 6.  Too much to handle - how gaining chromosomes destabilizes the genome.

Authors:  Verena Passerini; Zuzana Storchová
Journal:  Cell Cycle       Date:  2016-09-16       Impact factor: 4.534

7.  Copy number variants are produced in response to low-dose ionizing radiation in cultured cells.

Authors:  Martin F Arlt; Sountharia Rajendran; Shanda R Birkeland; Thomas E Wilson; Thomas W Glover
Journal:  Environ Mol Mutagen       Date:  2013-12-10       Impact factor: 3.216

8.  Replication stress induces genome-wide copy number changes in human cells that resemble polymorphic and pathogenic variants.

Authors:  Martin F Arlt; Jennifer G Mulle; Valerie M Schaibley; Ryan L Ragland; Sandra G Durkin; Stephen T Warren; Thomas W Glover
Journal:  Am J Hum Genet       Date:  2009-02-19       Impact factor: 11.025

9.  Analysis of the t(3;8) of hereditary renal cell carcinoma: a palindrome-mediated translocation.

Authors:  Takema Kato; Colleen P Franconi; Molly B Sheridan; April M Hacker; Hidehito Inagakai; Thomas W Glover; Martin F Arlt; Harry A Drabkin; Robert M Gemmill; Hiroki Kurahashi; Beverly S Emanuel
Journal:  Cancer Genet       Date:  2014-03-18

10.  Adaptive evolution of pelvic reduction in sticklebacks by recurrent deletion of a Pitx1 enhancer.

Authors:  Yingguang Frank Chan; Melissa E Marks; Felicity C Jones; Guadalupe Villarreal; Michael D Shapiro; Shannon D Brady; Audrey M Southwick; Devin M Absher; Jane Grimwood; Jeremy Schmutz; Richard M Myers; Dmitri Petrov; Bjarni Jónsson; Dolph Schluter; Michael A Bell; David M Kingsley
Journal:  Science       Date:  2009-12-10       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.